pharmaceutical company Pfizer Inc. reported that revenue for the past quarter of the fiscal year increased by 25%. This was not prevented even by the fact that sales of the actively promoted drug Lipitor decreased significantly.
Lipitor is a remedy for removing excess cholesterol from the body. Once one of the best-selling in the world. Now sales in the US (Pfizer's main market) have dropped by as much as 53% to $1.2 billion.
However, the company posted a net income of $3.3 billion (43 cents per share), well above the $2.61 billion earned in the same period last year. Pfizer representatives report that they managed to achieve this by restructuring the company, optimizing advertising, marketing and production costs.
As a result, Pfizer shares rose in price. At the time of writing the news, their cost was $ 24.12.